Sign in
4

Changes in Ownership

Oric Pharmaceuticals, Inc. Filed Acc 0001415889-24-015475

Director acquired 20,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kunkel Lori Anne Director 2024-06-03 Option exercise +20,500 $3.75 $76,875 20,500 D
Derivatives
Kunkel Lori Anne Director 2024-06-03 Option exercise · Stock Option (right to buy) −20,500 33,200 D
Loading xslF345X05/form4-06042024_100642.xml…